Catalyst Wire Dossier Catalyst Wire Dossier

Orsiro Drug-Eluting Stent

sirolimus-eluting stent · Biotronik AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Orsiro Drug-Eluting Stent, covering 2013-04-04 to 2013-04-04. Get the full timeline:

Most recent: Clinical Trial Update: BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions [NA]

See pricing